Literature DB >> 8158022

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections.

M L O'Ryan1, D O Matson, M K Estes, L K Pickering.   

Abstract

Serum VP7 (G) type- and isotype-specific anti-rotavirus antibodies were assessed among children monitored longitudinally over one or two rotavirus seasons in day care centers. Seventy-five pairs of blood specimens from 63 children were tested for anti-rotavirus antibodies. Stool specimens were collected weekly and tested for rotavirus antigen. G typing of detected rotaviruses showed that seven outbreaks of G1 and one of G3 occurred during the two seasons. G type-specific responses to the outbreak strain occurred among 79% of infected children and 9% of children with infection not detected (P < .001). Of children infected with G1, 54% had a heterotypic response; they were older (P = .048) and had higher preexisting G1 antibody levels than children who had only homotypic responses (P = .012). Higher IgA, IgG, and homotypic antibody levels to the antigenic site C of the G1 and G3 VP7s correlated with protection against infection and illness, homotypic antibody independently of IgA or IgG titers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158022     DOI: 10.1093/infdis/169.3.504

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Rotavirus-specific T-cell responses in young prospectively followed-up children.

Authors:  M Mäkelä; J Marttila; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 2.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

3.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Serum IgG mediates mucosal immunity against rotavirus infection.

Authors:  Larry E Westerman; Harold M McClure; Baoming Jiang; Jeffrey W Almond; Roger I Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

5.  Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota.

Authors:  Min Li; Marcia H Monaco; Mei Wang; Sarah S Comstock; Theresa B Kuhlenschmidt; George C Fahey; Michael J Miller; Mark S Kuhlenschmidt; Sharon M Donovan
Journal:  ISME J       Date:  2014-02-13       Impact factor: 10.302

6.  Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.

Authors:  Myron J Levin; Jane C Lindsey; Susan S Kaplan; Werner Schimana; Jody Lawrence; Monica M McNeal; Mutsa Bwakura-Dangarembizi; Anthony Ogwu; Evans M Mpabalwani; Paul Sato; George Siberry; Margaret Nelson; Darcy Hille; Geoffrey A Weinberg; Adriana Weinberg
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

7.  Molecular Analysis of VP7 Gene of Rotavirus G1 Strains Isolated from North India.

Authors:  Swapnil Jain; Jitendraa Vashistt; Kanika Gupta; Ashok Kumar; Harish Changotra
Journal:  Curr Microbiol       Date:  2016-08-26       Impact factor: 2.188

Review 8.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

10.  Group A rotavirus G type prevalence in two regions of Hungary.

Authors:  G Szücs; D O Matson; M Uj; E Kukán; I Mihály; Z Jelenik; M K Estes
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.